ES8606489A1 - Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura - Google Patents

Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura

Info

Publication number
ES8606489A1
ES8606489A1 ES537994A ES537994A ES8606489A1 ES 8606489 A1 ES8606489 A1 ES 8606489A1 ES 537994 A ES537994 A ES 537994A ES 537994 A ES537994 A ES 537994A ES 8606489 A1 ES8606489 A1 ES 8606489A1
Authority
ES
Spain
Prior art keywords
human interleukin
protein
glycosylated human
esp
column chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537994A
Other languages
English (en)
Other versions
ES537994A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16823684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8606489(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES537994A0 publication Critical patent/ES537994A0/es
Publication of ES8606489A1 publication Critical patent/ES8606489A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

UN METODO DE PRODUCIR UNA PROTEINA DE INTERLEUQUINA-2 HUMANA NO GLICOSILADA, SUSTANCIALMENTE PURA. SE OBTIENE CULTIVANDO UN TRANSFORMANTE QUE LLEVA UN ADN QUE TIENE UNA SECUENCIA DE BASES QUE CODIFICA INTERLEUQUINA-2 HUMANA PARA CAUSAR LA PRODUCCION Y ACUMULACION DE INTERLEUQUINA-2 HUMANA EN EL CALDO DE CULTIVO, Y SOMETIENDO EL LIQUIDO QUE CONTIENE INTERLEUQUINA-2 HUMANA, ASI OBTENIDO, A UN PROCEDIMIENTO DE PURIFICACION QUE COMPRENDE UNA CROMATOGRAFIA EN COLUMNA HIDROFOBA.
ES537994A 1983-11-28 1984-11-27 Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura Expired ES8606489A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58225079A JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物

Publications (2)

Publication Number Publication Date
ES537994A0 ES537994A0 (es) 1986-04-01
ES8606489A1 true ES8606489A1 (es) 1986-04-01

Family

ID=16823684

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537994A Expired ES8606489A1 (es) 1983-11-28 1984-11-27 Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura

Country Status (16)

Country Link
US (1) US5464939A (es)
EP (3) EP0442538A1 (es)
JP (1) JPS60115528A (es)
KR (1) KR920006879B1 (es)
DK (1) DK164174C (es)
ES (1) ES8606489A1 (es)
FI (1) FI81118C (es)
GR (1) GR81040B (es)
HU (1) HU200793B (es)
IL (1) IL73530A0 (es)
MY (1) MY103892A (es)
NO (1) NO169021C (es)
NZ (1) NZ210352A (es)
PT (1) PT79555B (es)
SG (1) SG46452A1 (es)
ZA (1) ZA849221B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
ZA849910B (en) * 1983-12-23 1985-09-25 Hoffmann La Roche Purification of recombinant interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
JPS60243021A (ja) * 1984-03-28 1985-12-03 シタス　コ−ポレイシヨン システイン含有蛋白質の制御された酸化方法
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−２の製造方法
EP0226639B1 (en) * 1985-05-29 1990-11-14 The Green Cross Corporation Process for preparing heterogenic protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
EP0227833B1 (en) * 1985-07-16 1991-01-16 Green Cross Corporation Process for preparing hetero-protein
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
CN86104525A (zh) * 1985-07-31 1987-02-25 武田药品工业株式会社 人类白细胞介素-2的分析方法和试剂
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
JPH0655153B2 (ja) * 1986-02-26 1994-07-27 武田薬品工業株式会社 ヒトインターロイキン―２結晶の製造法
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
US5149788A (en) * 1987-05-19 1992-09-22 Hoffmann-La Roche, Inc. Purification of chimeric proteins containing an IL-2 moiety by receptor-affinity chromatography
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
ES2545090T3 (es) 2001-12-21 2015-09-08 Human Genome Sciences, Inc. Proteínas de fusión de albúmina y GCSF
GB201000693D0 (en) 2010-01-15 2010-03-03 Isis Innovation A solar cell
EA037083B1 (ru) * 2010-11-12 2021-02-03 Нектар Терапьютикс Иммуномодулирующий конъюгат, включающий il-2 и водорастворимые полимеры
CN113230384A (zh) 2014-10-09 2021-08-10 丹娜法伯癌症研究院 用于治疗免疫失调的多次-可变il-2剂量方案

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
JPS58168492A (ja) * 1982-03-31 1983-10-04 Nippon Kokan Kk <Nkk> パイプ切断機
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
JPS58201979A (ja) * 1982-05-18 1983-11-25 Japan Found Cancer ヒトインタ−ロイキン２遺伝子が組込まれているエシエリヒア・コリおよびその育種方法
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
JPS58198293A (ja) * 1982-05-12 1983-11-18 Shionogi & Co Ltd インタ−ロイキン等免疫調節因子の製造方法
NL8203321A (nl) * 1982-08-25 1984-03-16 Philips Nv Kleurenbeeldbuis.
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
ZA849910B (en) * 1983-12-23 1985-09-25 Hoffmann La Roche Purification of recombinant interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
JP2608730B2 (ja) * 1987-08-10 1997-05-14 株式会社リコー 感熱記録材料

Also Published As

Publication number Publication date
FI81118C (fi) 1990-09-10
FI844678L (fi) 1985-05-29
HUT36186A (en) 1985-08-28
FI81118B (fi) 1990-05-31
KR920006879B1 (ko) 1992-08-21
AU592527B2 (en) 1990-01-18
NO844710L (no) 1985-05-29
EP0145390A2 (en) 1985-06-19
IL73530A0 (en) 1985-02-28
DK164174C (da) 1992-10-05
HU200793B (en) 1990-08-28
NO169021B (no) 1992-01-20
EP0442538A1 (en) 1991-08-21
ZA849221B (en) 1986-07-30
US5464939A (en) 1995-11-07
PT79555A (en) 1984-12-01
KR850003734A (ko) 1985-06-26
FI844678A0 (fi) 1984-11-28
ES537994A0 (es) 1986-04-01
NO169021C (no) 1992-04-29
SG46452A1 (en) 1998-02-20
JPH0542413B2 (es) 1993-06-28
AU3575684A (en) 1985-06-06
EP0145390A3 (en) 1987-01-21
JPS60115528A (ja) 1985-06-22
NZ210352A (en) 1988-11-29
EP0751220A1 (en) 1997-01-02
MY103892A (en) 1993-10-30
DK560784D0 (da) 1984-11-27
DK560784A (da) 1985-05-29
GR81040B (en) 1985-03-27
PT79555B (en) 1986-12-15
DK164174B (da) 1992-05-18

Similar Documents

Publication Publication Date Title
ES8606489A1 (es) Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura
EP2210947A3 (en) Method for producing secreted proteins
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
NZ310710A (en) Fermentative production of hydrophobic proteins such as ifn-&lt;beta&gt;
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
EP0187680A3 (en) Process for producing organic acids by use of microorganisms
EP0111389A3 (en) Substantially pure porcine growth hormone, dna sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone
ES2000030A6 (es) Metodo de purificar factor sanguineo viii:c
AU2624788A (en) Method of purifying protein
FI880889A (fi) Menetelmä vankomysiinityyppisen glykopeptidiantibiootin talteenottamiseksi
AU6504490A (en) A method for the purification of transforming growth factor (tgf-)
KR840008697A (ko) 상동 효모 신호를 이용한 이종단백질의 합성, 분비 및 표현매개체 제조방법
PT81265A (en) Improved process for the production of antibiotic derivatives of a-21978c cyclic peptides
IE872420L (en) Preparing antibiotic a40926 complex
EP0171000A3 (en) Process for producing heterologous matured protein or peptide
AU5602286A (en) Continuous process for ethanol production by bacterial fermentation
CA2084186A1 (en) Purification of human interleukin-4 secreted from a escherichia coli mutant
ES8705041A1 (es) Un metodo para producir interleuquina-2
HUT50360A (en) Process for producing antibiotic uk-61689 by microbiological way and pharmaceutical composition comprising the active ingredient and mycelium
MC1627A1 (fr) Procede de production d&#39;un interferon immun
GR3021593T3 (en) Fermentative method of preparing 2-hydroxyphenylacetic acid.
IL81751A (en) Continuous fermentation process for producing bacterial cells comprising use of high mineral salt feed for high yields and high productivity
GR3022960T3 (en) Process for the selective increase of production of antibiotic ge 2270 factor a.
PL139755B1 (en) Method of controlling microorganism culture nutrient feeding rate in particular for production of backing yeast

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401